Astrocyte involvement in blood–brain barrier function: a critical update highlighting novel, complex, neurovascular interactions

Manu, Doina Ramona ORCID: https://orcid.org/0000-0001-8374-4977, Slevin, Mark ORCID: https://orcid.org/0000-0003-3767-4861, Barcutean, Laura ORCID: https://orcid.org/0000-0002-3033-0583, Forro, Timea ORCID: https://orcid.org/0000-0002-5137-1819, Boghitoiu, Tudor and Balasa, Rodica (2023) Astrocyte involvement in blood–brain barrier function: a critical update highlighting novel, complex, neurovascular interactions. International Journal of Molecular Sciences, 24 (24). 17146. ISSN 1661-6596

Preview

Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview

Abstract

Neurological disorders have been linked to a defective blood–brain barrier (BBB), with dysfunctions triggered by stage-specific disease mechanisms, some of these being generated through interactions in the neurovascular unit (NVU). Advanced knowledge of molecular and signaling mechanisms in the NVU and the emergence of improved experimental models allow BBB permeability prediction and the development of new brain-targeted therapies. As NVU constituents, astrocytes are the most numerous glial cells, characterized by a heterogeneity that occurs as a result of developmental and context-based gene expression profiles and the differential expression of non-coding ribonucleic acids (RNAs). Due to their heterogeneity and dynamic responses to different signals, astrocytes may have a beneficial or detrimental role in the BBB’s barrier function, with deep effects on the pathophysiology of (and on the progression of) central nervous system diseases. The implication of astrocytic-derived extracellular vesicles in pathological mechanisms, due to their ability to pass the BBB, must also be considered. The molecular mechanisms of astrocytes’ interaction with endothelial cells at the BBB level are considered promising therapeutic targets in different neurological conditions. Nevertheless, a personalized and well-founded approach must be addressed, due to the temporal and spatial heterogeneity of reactive astrogliosis states during disease.